Why Is Biopharma Paying 75% Of The FDA’s Drug Division Budget?

It decreed that drug companies must pay a “user fee” each time they filed a New Drug Application (NDA). These funds would then be used to support the FDA’s drug division.

Read the full post at Forbes - Healthcare
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive